Recent Blog Posts
View Post: ANTI-CANCER
2 Dec 2009
Slide 52: D. MITOMYCIN • Activated to form an alkylating agent…> cross links DNA • IV given; hepatic metabolism • USE: adenocarcinoma of the cervix, stomach, pancreas & lungs • Causes myelosuppression ...
View Blog: Recent plicks from myplick.com - http://www.myplick.com/
View Post: Molecular Cancer
Full text
Mitomycin C induces bystander ... ...
View Blog: Mitomycin C (MMC) is one such drug used for treating solid tumors including hepatocellular carcinoma and cervical cancer [9-12]. It is already known that chemotherapeutic DNA-alkylating agents can induce in vivo and in vitro paracrine
View Post: Intravesical gemcitabine versus mitomycin in recurrent superficial ...
20 Oct 2009
Mitomycin (MMC) has been shown to be active in the treatment of superficial bladder cancer and given in multiple infusions produces response rates ranging from 40-50%; this has become one of the standard chemotherapy agents used in this ...
View Blog: NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/
View Post: Intravesical Chemotherapy of High-Grade Bladder Cancer with HTI ...
3 Mar 2008 by Hadaschik, BA, Adomat, H., Fazli, L., Fradet,...
Experimental Design: Various bladder cancer cell lines were treated with HTI-286 and mitomycin C (MMC) in vitro. Human KU-7 bladder tumor cells that stably express firefly luciferase were inoculated in female nude mice by intravesical ...
View Blog: Clinical Cancer Research recent issues - http://clincancerres.aacrjournals.org/
View Post: GEMCITABINE BETTAR TAHN MITOMYCIN FOR BLADDER CANCER
23 Oct 2009 by Dr. NICK
We compare the therapeutic efficacy and toxicity of intravescical infusions of gemcitabine (GEM) with mitomycin (MMC) in patients with a recurrent superficial bladder cancer. PATIENTS AND METHODS: Patients with a history of a previously ...
View Blog: CANCER AND IMPORTANT MEDICAL NEWS - http://cancerology.blogspot.com/
View Post: Mesothelioma and Drug Treatment
19 Oct 2009 by Ann-Marie Waters ...
View Blog: http://www.mesotheliomalungs.org/
View Post: GASTROINTESTINAL CANCER PART-13
25 Nov 2009 by Dr Chirag A Shah
Cisplatin appears to be of similar efficacy as mitomycin in phase 2 trials, but at least one randomized trial showed higher rate of colostomy with cisplatin compared with mitomycin. Que: What about patients with HIV and Anal Cancer? ...
View Blog: SHYAM CLINIC - http://shyamclinic.blogspot.com/
View Post: Liver Cancer Clinical Trial: Chemoembolization With or Without ...
29 Oct 2009
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery. RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, mitomycin, and cisplatin, ...
View Blog: Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r...
View Post: Cancer notice Cancer usage В» Bladder cancer usage
1 Dec 2009
Common agegts include rhiotepa, mitomycin, doxorubici n, anr BCG, thw latyer being the most sffective agent when compared with tthe others. Side effects of intravesical chemotherapy include irritative voiding eymptoms and hemorrhagic ...
View Blog: damonbragg - http://www.liveinternet.ru/users/damonbragg/
View Post: concurrent chemoradiotherapy with 5-fluorouracil and mitomycin c …
16 Sep 2009 by admin
conclusion. our data have confirmed that in the highly active antiretroviral therapy era, hiv-related anal cancer can be treated with standard crt without dose reductions. close surveillance of the immunologic parameters is necessary. ...
View Blog: Anal Cancer - http://analcancersite.com/

Not Signed In -

